Error disclosure in neonatal intensive care: a multicentre, prospective, observational study.
attitudes
communication
medical error, measurement/epidemiology
paediatrics
patient safety
Journal
BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
07
06
2022
accepted:
08
11
2022
medline:
21
9
2023
pubmed:
15
3
2023
entrez:
14
3
2023
Statut:
ppublish
Résumé
Surveys based on hypothetical situations suggest that health-care providers agree that disclosure of errors and adverse events to patients and families is a professional obligation but do not always disclose them. Disclosure rates and reasons for the choice have not previously been studied. To measure the proportion of errors disclosed by neonatal intensive care unit (NICU) professionals to parents and identify motives for and barriers to disclosure. Prospective, observational study nested in a randomised controlled trial (Study on Preventing Adverse Events in Neonates (SEPREVEN); ClinicalTrials.gov). Event disclosure was not intended to be related to the intervention tested. 10 NICUs in France with a 20-month follow-up, starting November 2015. n=1019 patients with NICU stay ≥2 days with ≥1 error. Characteristics of errors (type, severity, timing of discovery), patients and professionals, self-reported motives for disclosure and non-disclosure. Rate of error disclosure reported anonymously and voluntarily by physicians and nurses; perceived parental reaction to disclosure. Among 1822 errors concerning 1019 patients (mean gestational age: 30.8±4.5 weeks), 752 (41.3%) were disclosed. Independent risk factors for non-disclosure were nighttime discovery of error (OR 2.40; 95% CI 1.75 to 3.30), milder consequence (for moderate consequence: OR 1.85; 95% CI 0.89 to 3.86; no consequence: OR 6.49; 95% CI 2.99 to 14.11), a shorter interval between admission and error, error type and fewer beds. The most frequent reported reasons for non-disclosure were parental absence at its discovery and a perceived lack of serious consequence. In the particular context of the SEPREVEN randomised controlled trial of NICUs, staff did not disclose the majority of errors to parents, especially in the absence of moderate consequence for the infant. NCT02598609.
Identifiants
pubmed: 36918264
pii: bmjqs-2022-015247
doi: 10.1136/bmjqs-2022-015247
doi:
Banques de données
ClinicalTrials.gov
['NCT02598609']
Types de publication
Randomized Controlled Trial
Observational Study
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
589-599Investigateurs
Dominique Astruc
(D)
Valérie Biran
(V)
Leila Marcus
(L)
Laurent Beghin
(L)
Bernard Guillois
(B)
Radia Remichi
(R)
Faiza Harbi
(F)
Xavier Durrmeyer
(X)
Florence Casagrande
(F)
Nolwenn Lesaché
(N)
Darina Todorova
(D)
Ali Bilal
(A)
Damien Olivier
(D)
Audrey Reynaud
(A)
Cécile Jacquin
(C)
Jean-Christophe Roze
(JC)
Claude Danan
(C)
Fabrice Decobert
(F)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.